Your session is about to expire
← Back to Search
Device
Treadmetrix Validation for Balance Assessment
N/A
Waitlist Available
Led By Kenton Kaufman, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Healthy adults with no medical conditions or previous injuries, trauma, or surgeries that reduce balance, mobility, or strength
Be between 18 and 65 years old
Must not have
Current or chronic pain in shoulders, elbows, hips, knees, ankles, feet, neck, or back
Use of assistive device such as walker or cane
Timeline
Screening 3 weeks
Treatment Varies
Follow Up duration of participant test session (approximately 2 hours)
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a special treadmill that uses a computer to control its movements. It is likely aimed at people who need to test or improve their balance. The treadmill creates specific movements to see how well someone can stay balanced.
Who is the study for?
This trial is for healthy adults who can follow instructions and have no medical conditions, injuries, or surgeries affecting balance, mobility, or strength. There are no restrictions based on gender, race, or ethnicity. People with chronic pain in major joints or the back or those using assistive devices like walkers cannot participate.
What is being tested?
The study is testing 'Treadmetrix', a microprocessor-controlled treadmill designed to deliver controlled postural disturbances. The goal is to validate how accurately this equipment can simulate these disturbances for research purposes.
What are the potential side effects?
Since this trial involves physical activity on a treadmill that simulates disturbances in posture, potential side effects may include muscle soreness, fatigue, and risk of falls during the test.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a healthy adult with no conditions or past injuries affecting my balance, mobility, or strength.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have ongoing pain in my joints or back.
Select...
I use a walker or cane for mobility.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ duration of participant test session (approximately 2 hours)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~duration of participant test session (approximately 2 hours)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Estimate the limits of agreement between observed and commanded treadmill belt disturbance parameters: average initial acceleration.
Estimate the limits of agreement between observed and commanded treadmill belt disturbance parameters: belt displacement.
Estimate the limits of agreement between observed and commanded treadmill belt disturbance parameters: peak velocity.
Secondary study objectives
Kinetic loading exerted on treadmill during perturbations: treadmill force.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Balance assessment on specialized treadmillExperimental Treatment1 Intervention
Subjects will undergo a balance assessment on a microprocessor-controlled treadmill
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for healthy subjects often include physical activity and exercise, which work by enhancing cardiovascular health, improving muscle strength, and increasing flexibility. These activities stimulate neuroplasticity, improve balance, and enhance overall physical function.
The microprocessor-controlled treadmill, which delivers controlled postural disturbances, specifically targets balance and coordination by challenging the body's stability mechanisms. This is particularly important for healthy subjects as it can prevent falls, improve proprioception, and maintain functional independence.
Vestibular and balance rehabilitation therapy.The Effect of Walking Intervention on Cognitive Function Among Patients With Non-Central Nervous System Cancer: A Systematic Review.Effectiveness of instrument-assisted soft tissue mobilization for the management of upper body, lower body, and spinal conditions. An updated systematic review with meta-analyses.
Vestibular and balance rehabilitation therapy.The Effect of Walking Intervention on Cognitive Function Among Patients With Non-Central Nervous System Cancer: A Systematic Review.Effectiveness of instrument-assisted soft tissue mobilization for the management of upper body, lower body, and spinal conditions. An updated systematic review with meta-analyses.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,353 Previous Clinical Trials
3,061,003 Total Patients Enrolled
Kenton Kaufman, PhDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
80 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am willing to participate in the study.I can understand and follow basic instructions.I am a healthy adult with no conditions or past injuries affecting my balance, mobility, or strength.I am a healthy adult with no conditions or past injuries affecting my balance, mobility, or strength.My gender, race, or ethnicity does not affect my eligibility.I have ongoing pain in my joints or back.I use a walker or cane for mobility.I am willing to participate in the study.
Research Study Groups:
This trial has the following groups:- Group 1: Balance assessment on specialized treadmill
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.